Wei N, Burnett J, Crocker D, Huang Y, Li S, Wipf P
Biochem Pharmacol. 2023; 212:115564.
PMID: 37116665
PMC: 11225567.
DOI: 10.1016/j.bcp.2023.115564.
Thomas W, Pronin S
J Am Chem Soc. 2021; 144(1):118-122.
PMID: 34958202
PMC: 10122274.
DOI: 10.1021/jacs.1c12283.
Klein V, Bray W, Wang H, Edmondson Q, Schwochert J, Ono S
ACS Chem Biol. 2021; 16(8):1354-1364.
PMID: 34251165
PMC: 8545353.
DOI: 10.1021/acschembio.1c00094.
Hwang N, Pei Y, Clement J, Robertson E, Du Y
Bioorg Med Chem Lett. 2020; 30(23):127553.
PMID: 32971261
PMC: 7704689.
DOI: 10.1016/j.bmcl.2020.127553.
Johnson T, Istifanus G, Kutshik R
J Parasit Dis. 2020; 44(1):166-173.
PMID: 32174721
PMC: 7046872.
DOI: 10.1007/s12639-019-01178-4.
The NCI library of traditional Chinese medicinal plant extracts - Preliminary assessment of the NCI-60 activity and chemical profiling of selected species.
He M, Grkovic T, Evans J, Thornburg C, Akee R, Thompson J
Fitoterapia. 2019; 137:104285.
PMID: 31386897
PMC: 7391999.
DOI: 10.1016/j.fitote.2019.104285.
A viral RNA motif involved in signaling the initiation of translation on non-AUG codons.
Sanz M, Almela E, Garcia-Moreno M, Marina A, Carrasco L
RNA. 2019; 25(4):431-452.
PMID: 30659060
PMC: 6426287.
DOI: 10.1261/rna.068858.118.
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials.
Sheridan C, Garcia V, Ahyong V, DeRisi J
Malar J. 2018; 17(1):465.
PMID: 30541569
PMC: 6292128.
DOI: 10.1186/s12936-018-2616-7.
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
Wei N, Li J, Fang C, Chang J, Xirou V, Syrigos N
Oncogene. 2018; 38(10):1676-1687.
PMID: 30348989
DOI: 10.1038/s41388-018-0547-y.
Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.
Oh E, Kim C, Kim H, Lee J, Park H
Theranostics. 2017; 7(14):3415-3431.
PMID: 28912885
PMC: 5596433.
DOI: 10.7150/thno.20861.
Antiplasmodial activity and cytotoxicity of ethanol extract of root.
Okokon J, Antia B, Azare B, Okokon P
Avicenna J Phytomed. 2017; 7(3):275-284.
PMID: 28748174
PMC: 5511979.
Brusatol overcomes chemoresistance through inhibition of protein translation.
Harder B, Tian W, La Clair J, Tan A, Ooi A, Chapman E
Mol Carcinog. 2016; 56(5):1493-1500.
PMID: 28019675
PMC: 5404829.
DOI: 10.1002/mc.22609.
Bruceantin inhibits multiple myeloma cancer stem cell proliferation.
Issa M, Berndt S, Carpentier G, Pezzuto J, Cuendet M
Cancer Biol Ther. 2016; 17(9):966-75.
PMID: 27434731
PMC: 5036415.
DOI: 10.1080/15384047.2016.1210737.
The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.
Hall I, Hall E, Miller 3rd M, Sood A, Spielvogel B
Amino Acids. 2013; 4(3):287-302.
PMID: 24190609
DOI: 10.1007/BF00805829.
Cytotoxicity of boron containing dipeptide analogs.
Karthikeyan S, Sood A, Tomasz J, Spielvogel B, Hall I
Amino Acids. 2013; 8(4):323-35.
PMID: 24186510
DOI: 10.1007/BF00806550.
Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.
Usami Y, Nakagawa-Goto K, Lang J, Kim Y, Lai C, Goto M
J Nat Prod. 2010; 73(9):1553-8.
PMID: 20738103
PMC: 2954497.
DOI: 10.1021/np100406d.
Altering chemosensitivity by modulating translation elongation.
Robert F, Carrier M, Rawe S, Chen S, Lowe S, Pelletier J
PLoS One. 2009; 4(5):e5428.
PMID: 19412536
PMC: 2671598.
DOI: 10.1371/journal.pone.0005428.
U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.
Gurel G, Blaha G, Moore P, Steitz T
J Mol Biol. 2009; 389(1):146-56.
PMID: 19362093
PMC: 2682339.
DOI: 10.1016/j.jmb.2009.04.005.
A distinct translation initiation mechanism generates cryptic peptides for immune surveillance.
Starck S, Ow Y, Jiang V, Tokuyama M, Rivera M, Qi X
PLoS One. 2008; 3(10):e3460.
PMID: 18941630
PMC: 2565129.
DOI: 10.1371/journal.pone.0003460.
Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren A, Shalaby T, Rajtarova J, Stearns D, Eberhart C, Helson L
BMC Cancer. 2007; 7:19.
PMID: 17254356
PMC: 1794252.
DOI: 10.1186/1471-2407-7-19.
